IP Library Granted Patent US 7,487,780
Granted Patent B2
US 7,487,780 · App. 10/927,746 · Granted Feb 10, 2009

Sub-xyphoid method for ablating cardiac tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,487,780
App. No.
10/927,746
Granted
Feb 10, 2009
Kind
B2
Abstract

A method and apparatus for transmural ablation using an instrument containing two electrodes or cryogenic probes. A clamping force is exerted on the two electrodes or probes such that the tissue of the hollow organ is clamped therebetween. Bipolar RF energy is then applied between the two electrodes, or the probes are cryogenically cooled, thus ablating the tissue therebetween. The method provides for ablating cardiac tissue of a patient utilizing a sub-xyphoid approach and identifying cardiac tissue prior to ablation.

Claims (63)

1. A method for ablating cardiac tissue of a patient employing sub-xyphoid access, the method including:

making a percutaneous incision proximal to the xiphoid to define an instrument receiving passage;

providing an ablation instrument including first and second elongated jaw members, the elongated jaw members being relatively moveable between a first open position and a second clamped position, each jaw member including at least one ablation member adapted to be connected to an ablation energy source, the ablation members being disposed to engage cardiac tissue at a selected cardiac location to ablate tissue therebetween;

introducing a fluid into an intrapericardial space to create and maintain a working space for accessing the selected cardiac location;

inserting the ablation instrument through the instrument receiving passage to a sub-xyphoid region;

advancing the ablation instrument through the sub-xyphoid region into the intrapericardial space to the selected cardiac location;

clamping the cardiac tissue between the first and second jaw members at the selected cardiac location; and

ablating the cardiac tissue at the selected location by energizing the ablation members.

2. The method of claim 1 wherein introducing fluid is performed at least in part during clamping.

3. The method of claim 1 further including:

providing a locating instrument for identifying the selected cardiac location, the locating instrument including an elongated body and a distal end;

inserting the locating instrument through the instrument receiving passage to the sub-xyphoid region;

advancing the locating instrument through the sub-xyphoid region to the selected cardiac location; and

identifying the selected cardiac location prior to ablation.

4. The method of claim 3 wherein the ablation instrument and the locating instrument are integrally connected as a single combined instrument.

5. The method of claim 1 wherein introducing fluid is continuous and creates a positive pressure within the intrapericardial space.

6. The method of claim 1 wherein introducing fluid injects a substantially clear fluid into the intrapericardial space for clear viewing of the selected cardiac location.

7. The method of claim 1 wherein introducing fluid includes, at least in part, separating the pericardium from the selected cardiac location.

8. The method of claim 1 wherein ablating comprises creating at least one ablation line in an atria adjacent at least one of the right and left pulmonary veins.

9. The method of claim 1 wherein ablating comprises creating a plurality of ablation lines at selected cardiac locations for treating atrial fibrillation.

10. The method of claim 9 wherein the plurality of ablation lines are disposed to create an electrical maze in the atrium.

11. The method of claim 1 wherein the ablation member is an electrode.

12. A method for identifying cardiac tissue for ablation, the method including:

making a percutaneous incision proximal to the xiphoid to define an instrument receiving passage;

providing a locating instrument for identifying a selected cardiac location, the locating instrument including an elongated body and a distal end;

inserting the locating instrument through the instrument receiving passage through a sub-xyphoid region;

advancing the locating instrument through the sub-xyphoid region to position the distal end within an intrapericardial space;

creating and maintaining a positive pressure within the intrapericardial space by injecting a fluid from the distal end into the intrapericardial space; and

identifying the selected cardiac location prior to ablation.

13. The method of claim 12 wherein creating a positive pressure comprises introducing saline into the intrapericardial space for clear viewing of the selected cardiac location.

14. The method of claim 12 further comprising manipulating the locating instrument to separate a pericardium from the selected cardiac location.

15. A method for identifying and ablating cardiac tissue, the method including:

making a percutaneous incision proximal to the xiphoid to define an instrument receiving passage;

providing a locating instrument for identifying a selected cardiac location, the locating instrument including an elongated body and a distal end;

providing an ablation instrument including first and second elongated jaw members, the elongated jaw members being relatively movable between a first open position and a second clamped position, each jaw member including at least one ablation member adapted to be connected to an ablation energy source, the ablation members being disposed to engage cardiac tissue at the selected cardiac location to ablate tissue therebetween;

introducing a fluid into an intrapericardial space to create and maintain a working space for accessing the selected cardiac location;

inserting the locating instrument through the instrument receiving passage to a sub-xyphoid region;

advancing the locating instrument through the sub-xyphoid region into the intrapericardial space to the selected cardiac location;

identifying the selected cardiac location prior to ablation;

inserting the ablation instrument through the instrument receiving passage to the sub-xyphoid region;

advancing the ablation instrument through the sub-xyphoid region into the intrapericardial space to the selected cardiac location;

clamping the cardiac tissue between the first and second jaw members at the selected cardiac location; and

ablating the cardiac tissue at the selected location by energizing the ablation members.

16. The method of claim 15 wherein the ablation instrument and the locating instrument are integrally connected as a single combined instrument such that inserting the locating and ablation instruments are performed simultaneously and advancing the locating and ablation instruments are performed simultaneously.

17. The method of claim 15 wherein ablating comprises creating at least one ablation line in the atria adjacent at least one of the right and left pulmonary veins.

18. The method of claim 15 wherein ablating comprises creating a plurality of ablation lines at selected cardiac locations for treating atrial fibrillation.

19. The method of claim 18 wherein the plurality of ablation lines are disposed to create an electrical maze in the atrium.

20. A method for identifying and ablating cardiac tissue, the method including:

making a percutaneous incision proximal to the xiphoid to define an instrument receiving passage;

providing a locating instrument for identifying a selected cardiac location, the locating instrument including an elongated body and a distal end;

providing a bi-polar ablation instrument including first and second jaw members, the jaw members being relatively movable between a first open position and a second clamped position, each jaw member including at least one ablation member adapted to be connected to an ablation energy source, the ablation members being disposed to engage cardiac tissue at the selected cardiac location to ablate tissue therebetween;

introducing a fluid into an intrapericardial space to create and maintain a working space for accessing the selected cardiac location;

inserting the locating instrument through the instrument receiving passage to a sub-xyphoid region;

advancing the locating instrument through the sub-xyphoid region into the intrapericardial space to the selected cardiac location;

identifying the selected cardiac location prior to ablation;

inserting the ablation instrument through the instrument receiving passage to the sub-xyphoid region;

advancing the ablation instrument through the sub-xyphoid region into the intrapericardial space to the selected cardiac location;

clamping the cardiac tissue between the first and second jaw members at the selected cardiac location; and

ablating the cardiac tissue at the selected location by energizing the ablation members.

21. The method of claim 20 wherein the ablation instrument and the locating instrument are integrally connected as a single combined instrument such that inserting the locating and ablation instruments are performed simultaneously and advancing the locating and ablation instruments are performed simultaneously.

22. The method of claim 20 wherein ablating comprises creating at least one ablation line in the atria adjacent at least one of the right and left pulmonary veins.

23. The method of claim 20 wherein ablating comprises creating a plurality of ablation lines at selected cardiac locations for treating atrial fibrillation.

24. The method of claim 20 wherein the plurality of ablation lines are disposed to create an electrical maze in the atrium.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2024
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC; SENTREHEART LLC
Reel/Frame 066256/0797 →
SECURITY INTEREST Recorded Dec 18, 2018
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC
To: SILICON VALLEY BANK
Reel/Frame 047951/0496 →
SECOND AMENDED AND RESTATED JOINT INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 25, 2016
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC
To: SILICON VALLEY BANK
Reel/Frame 038520/0062 →
SECURITY INTEREST Recorded May 2, 2014
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC
To: SILICON VALLEY BANK
Reel/Frame 032812/0032 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2004
From: HOOVEN, MICHAEL D.
To: ATRICURE INC.
Reel/Frame 015745/0110 →